Скачать или смотреть Future of Healthcare Technology: Neurotech breakthroughs and therapeutic disease prevention

SPEAKERS:
▶Matt Angle (CEO, Paradromics)
▶Konstantinos Alataris (Founder/x-CEO of Nevro)
▶Frank Fisher (Chairman Of The Board at NeuroPace)
▶Marcus Gerhardt (CEO, Blackrock Neurotech)

In this deep dive into the Future of Healthcare Technology, we explore the unstoppable momentum driving innovation, particularly in neurotech breakthroughs and advanced data analytics. The landscape of neurostimulation has transformed significantly, demonstrated by the success of companies like Nevro and Inspire Medical, who are successfully challenging established incumbents such as Boston Scientific, Abbott, and Medtronic.

Scientific progress is now focused on using expanded tools and technologies, including implantables or wearables, to address major system problems like chronic pain and chronic inflammation. Exciting new applications involve treating autoimmune disease by leveraging our understanding of pathways to retrain the brain and better control the immune response.

Beyond these specific treatments, a fundamental shift is occurring in data management: there is a critical and highly realistic goal of establishing a more effective means of gathering and analyzing data for the overall improvement of patient care. This focus on the easier flow of data and achieving efficiency in the hospital setup is exemplified by companies like Huma. Ultimately, this technological evolution is driving healthcare beyond diagnostic measures toward true therapeutic disease prevention, actively stopping the disease from developing.


Paradromics builds brain-computer interface (BCI) technologies for seamless human-technology integration, restoring and enhancing human capabilities.
https://www.paradromics.com/

#Healthcare #HealthcareTechnology #FutureofHealthcareTechnology